Nuveen Asset Management, LLC - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 193 filers reported holding DENALI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$7,502,408
-30.4%
363,665
-0.5%
0.00%
-25.0%
Q2 2023$10,784,606
+129694.3%
365,456
+1.3%
0.00%
+33.3%
Q1 2023$8,309
-20.5%
360,636
-4.0%
0.00%
-25.0%
Q4 2022$10,449
-99.9%
375,747
+6.9%
0.00%0.0%
Q3 2022$10,786,000
+1.8%
351,459
-2.4%
0.00%0.0%
Q2 2022$10,599,000
-14.1%
360,158
-2.7%
0.00%0.0%
Q1 2022$12,344,000
-26.6%
370,229
-1.8%
0.00%
-20.0%
Q4 2021$16,816,000
-12.8%
377,044
+3.3%
0.01%
-16.7%
Q3 2021$19,287,000
-36.0%
365,078
-4.9%
0.01%
-33.3%
Q2 2021$30,126,000
+90.0%
384,060
+38.3%
0.01%
+80.0%
Q1 2021$15,852,000
-35.2%
277,621
-4.9%
0.01%
-37.5%
Q4 2020$24,446,000
+107.8%
291,862
-11.1%
0.01%
+60.0%
Q3 2020$11,765,000
+47.6%
328,351
-0.4%
0.01%
+66.7%
Q2 2020$7,971,000
+60.6%
329,679
+16.3%
0.00%
+50.0%
Q1 2020$4,963,000
+57.9%
283,438
+57.1%
0.00%
+100.0%
Q4 2019$3,143,000
+14.5%
180,393
+0.6%
0.00%0.0%
Q3 2019$2,746,000
-24.4%
179,230
+2.4%
0.00%0.0%
Q2 2019$3,632,000174,9750.00%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Crestline Management, LP 7,705,039$343,645,00025.68%
Casdin Capital, LLC 1,500,000$66,900,0001.89%
Flagship Pioneering Inc. 2,619,968$116,851,0001.81%
SECTORAL ASSET MANAGEMENT INC 189,600$8,456,0001.27%
Integral Health Asset Management, LLC 100,000$4,460,0001.23%
Temasek Holdings (Private) Ltd 5,369,487$239,479,0000.86%
Goldstream Capital Management Ltd 78,418$3,497,0000.86%
Yiheng Capital Management, L.P. 335,184$14,949,0000.76%
GILDER GAGNON HOWE & CO LLC 2,900,114$129,345,0000.74%
Artal Group S.A. 600,000$26,760,0000.73%
View complete list of DENALI THERAPEUTICS INC shareholders